JP2011518828A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011518828A5 JP2011518828A5 JP2011506352A JP2011506352A JP2011518828A5 JP 2011518828 A5 JP2011518828 A5 JP 2011518828A5 JP 2011506352 A JP2011506352 A JP 2011506352A JP 2011506352 A JP2011506352 A JP 2011506352A JP 2011518828 A5 JP2011518828 A5 JP 2011518828A5
- Authority
- JP
- Japan
- Prior art keywords
- pai
- medicament
- compound
- combinations
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4817608P | 2008-04-26 | 2008-04-26 | |
| US61/048,176 | 2008-04-26 | ||
| US12/421,456 | 2009-04-09 | ||
| US12/421,456 US20090202524A1 (en) | 2007-10-31 | 2009-04-09 | Pai-1 expression and activity inhibitors for the treatment of ocular disorders |
| PCT/US2009/040149 WO2009131850A2 (en) | 2008-04-26 | 2009-04-10 | Pai-1 expression and activity inhibitors for the treatment of ocular disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011518828A JP2011518828A (ja) | 2011-06-30 |
| JP2011518828A5 true JP2011518828A5 (enExample) | 2013-03-14 |
Family
ID=40810596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011506352A Pending JP2011518828A (ja) | 2008-04-26 | 2009-04-10 | 眼球障害の処置のためのｐａｉ−１の発現および活性インヒビター |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20090202524A1 (enExample) |
| EP (1) | EP2296647A2 (enExample) |
| JP (1) | JP2011518828A (enExample) |
| KR (1) | KR20100135953A (enExample) |
| CN (1) | CN102046168A (enExample) |
| AR (1) | AR071393A1 (enExample) |
| CL (1) | CL2009000986A1 (enExample) |
| TW (1) | TW200946113A (enExample) |
| UY (1) | UY31786A1 (enExample) |
| WO (1) | WO2009131850A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005105069A1 (en) * | 2004-04-26 | 2005-11-10 | Alcon, Inc. | Statins for the treatment of ocular hypertension and glaucoma |
| US10946076B2 (en) * | 2013-02-13 | 2021-03-16 | The Research Foundation For The State University Of New York | Glaucoma treatment |
| BR112016002753A2 (pt) | 2013-08-13 | 2017-11-21 | Sanofi Sa | anticorpos contra o inibidor-1 de ativador de plasminogênio (pai-1) e usos dos mesmos |
| US10813920B2 (en) * | 2013-11-14 | 2020-10-27 | The Doshisha | Drug for treating corneal endothelium by promoting cell proliferation or inhibiting cell damage |
| EP3381472A4 (en) | 2015-12-24 | 2019-07-31 | The Doshisha | MEDICINAL PRODUCTS FOR THE TREATMENT OR PREVENTION OF DISTURBANCES CAUSED BY TGF SIGNALS AND USE THEREOF |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4214215A1 (de) * | 1992-04-30 | 1993-11-04 | Behringwerke Ag | Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen |
| AU771635B2 (en) * | 1999-01-05 | 2004-04-01 | American National Red Cross, The | Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| US7074817B2 (en) * | 2001-06-20 | 2006-07-11 | Wyeth | Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| EP1497420A4 (en) * | 2002-04-30 | 2005-04-27 | Alcon Inc | AGENTS THAT REGULATE, RESTRICT OR MODULATE THE ACTIVITY AND / OR EXPRESSION OF BIND WEAVE GROWTH FACTOR (CTGF) AS UNIQUE MEDICAMENTS BOTH TO REDUCE EYESPRINTS AND TREAT GLACCOMPETOSIS RETINOPATHIES / OPTIC NEUROPATHIES |
| JP2007512347A (ja) * | 2003-11-26 | 2007-05-17 | デューク・ユニバーシティー | 緑内障を予防するかまたは治療する方法 |
| WO2005105069A1 (en) * | 2004-04-26 | 2005-11-10 | Alcon, Inc. | Statins for the treatment of ocular hypertension and glaucoma |
| WO2006040839A1 (ja) * | 2004-10-15 | 2006-04-20 | Advanced Medicine Research Institute | 眼疾患処置用点眼剤及びキット |
| US20060094753A1 (en) * | 2004-10-29 | 2006-05-04 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| US7803824B2 (en) * | 2004-10-29 | 2010-09-28 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases to treat glaucoma |
| US8969295B2 (en) * | 2006-04-14 | 2015-03-03 | Massachusetts Institute Of Technology | Identifying and modulating molecular pathways that mediate nervous system plasticity |
| US20080107644A1 (en) * | 2006-10-31 | 2008-05-08 | Alcon Manufacturing, Ltd. | Pai-1 binding modulators for the treatment of ocular disorders |
-
2009
- 2009-04-09 US US12/421,456 patent/US20090202524A1/en not_active Abandoned
- 2009-04-10 EP EP09735222A patent/EP2296647A2/en not_active Withdrawn
- 2009-04-10 KR KR1020107026494A patent/KR20100135953A/ko not_active Withdrawn
- 2009-04-10 JP JP2011506352A patent/JP2011518828A/ja active Pending
- 2009-04-10 WO PCT/US2009/040149 patent/WO2009131850A2/en not_active Ceased
- 2009-04-10 CN CN2009801185568A patent/CN102046168A/zh active Pending
- 2009-04-21 TW TW098113153A patent/TW200946113A/zh unknown
- 2009-04-22 AR ARP090101418A patent/AR071393A1/es not_active Application Discontinuation
- 2009-04-24 UY UY31786A patent/UY31786A1/es not_active Application Discontinuation
- 2009-04-24 CL CL2009000986A patent/CL2009000986A1/es unknown
-
2011
- 2011-01-14 US US13/006,984 patent/US20110105574A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2018005695A1 (en) | Use of neurokinin-1 antagonists to treat a variety of pruritic conditions | |
| JP2022545835A5 (enExample) | ||
| KR102059027B1 (ko) | Hdac6 억제제를 유효성분으로 포함하는 가려움증 예방 또는 치료용 약제학적 조성물 | |
| JP2005343897A5 (enExample) | ||
| CN102655859A (zh) | 病毒感染的组合疗法治疗 | |
| EP1919466B9 (en) | Formulations for treatment of lipoprotein abnormalities comprising a statin and a methylnicotinamide derivative | |
| CA2335366A1 (en) | Compositions and methods for treating elevated blood cholesterol | |
| CN101939001B (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| JP2019529477A (ja) | 非アルコール性脂肪肝疾患治療のための医薬組成物および方法 | |
| CN101677984A (zh) | 地来西坦在治疗慢性疼痛中的应用 | |
| WO1999066930A1 (en) | Compositions and methods for treating elevated blood cholesterol | |
| KR20050085681A (ko) | 프로테아제 억제제와 같은 사이토크롬 ｐ450의 억제제와함께 비-뉴클레오시드 역전사효소 억제제(ｎｎｒｔｉ)를함유하는 배합물의 용도 | |
| ES2311986T3 (es) | Estatinas para el tratamiento de la hipertension ocular y del glaucoma. | |
| JP2010508306A5 (enExample) | ||
| KR20130137623A (ko) | 림프 부종 예방 치료제 | |
| JP2011157395A5 (enExample) | ||
| US11571468B2 (en) | Micronutrient combination to reduce blood pressure | |
| KR101258422B1 (ko) | 신규의 트리글리세리드 저하제 | |
| CA2480275A1 (en) | Statin therapy for enhancing cognitive maintenance | |
| US9974768B2 (en) | Pharmaceutical for improving dysphagia | |
| CN108114282B (zh) | 他汀类化合物治疗缺血性疾病的用途 | |
| WO2019216313A1 (ja) | 心血管疾患に有用な医薬 | |
| RU2007125976A (ru) | Способ уменьшения, стабилизации и предупреждения разрыва богатой липидами бляшки | |
| RU2007111704A (ru) | 4[(2,4-дихлоро-5-метоксифенил)амино]-6-алкокси-7-этинил-3-хинолинкарбонитрилы для лечения ишемического поражения | |
| JP2025116315A (ja) | 内頚動脈狭窄症の予防及び／又は治療薬 |